Table 5.
Accompanying Figure2
| |
Distress |
Worry |
Quality of life |
|---|---|---|---|
| Mean (95% CI) | Mean (95% CI) | Mean (95% CI) | |
| C-low/G-low |
1.52 (1.42 to 1.62) |
1.73 (1.63 to 1.84) |
28.0 (27.1 to 28.9) |
| C-high/G-high |
2.39* (2.21 to 2.56) |
1.82 (1.69 to 1.95) |
25.6* (24.4 to 26.9) |
| C-low/G-high (assigned to no CT) |
2.03* (1.64 to 2.41) |
1.77 (1.41 to 2.14) |
28.0 (24.9 to 31.1) |
| C-low/G-high (assigned to CT) |
2.71* (2.35 to 3.07) |
1.72 (1.40 to 2.05) |
26.3 (23.6 to 29.0) |
| C-high/G-low (assigned to no CT) |
2.11* (1.70 to 2.52) |
1.85 (1.61 to 2.10) |
26.9 (24.6 to 29.1) |
| C-high/G-low (assigned to CT) |
1.68 (1.45 to 1.91) |
1.49 (1.34 to 1.65) |
26.9 (25.1 to 28.8) |
| C-low/G-na |
1.95* (1.58 to 2.32) |
1.86 (1.61 to 2.10) |
26.0 (23.9 to 28.2) |
| C-high/G-na | 2.31* (2.11 to 2.51) | 1.95 (1.80 to 2.11) | 23.8* (22.5 to 25.2) |
Note. The reference group in analyses was C-low/G-low. C, clinical, G = genomic, CT, chemotherapy, na, result not available. n = 347.
*p < 0.01.